Literatur
Global Initiative for Asthma (GINA) (2009) NHLBI/WHO workshop report. National Heart, Lung and Blood Institute, National Institutes of Health. 2009. Bethesda, Md. www ginasthma com – updated Dezember 2009
Bousquet J, Ben-Joseph R, Messonnier M et al (2002) A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma. Clin Ther 24(1):1–20
Magnussen H, Bugnas B, Noord J van et al (2008) Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med 102(1):50–56
Park HW, Yang MS, Park CS et al (2009) Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response. Allergy 64(5):778–783
Curfman GD, Morrissey S, Drazen JM (2010) Products at risk. N Engl J Med 363(18):1763
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehungen hin: Referententätigkeit für Novartis und Boehringer Ingelheim, Investigator in zahlreichen Studien (AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline und Novartis).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Korn, S. Tiotropium bei Patienten mit unkontrolliertem Asthma. Pneumologe 8, 176–178 (2011). https://doi.org/10.1007/s10405-010-0462-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-010-0462-6